Correlation Between NYSE Composite and Lipella Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Lipella Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Lipella Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Lipella Pharmaceuticals Common, you can compare the effects of market volatilities on NYSE Composite and Lipella Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Lipella Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Lipella Pharmaceuticals.
Diversification Opportunities for NYSE Composite and Lipella Pharmaceuticals
0.4 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between NYSE and Lipella is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Lipella Pharmaceuticals Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lipella Pharmaceuticals and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Lipella Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lipella Pharmaceuticals has no effect on the direction of NYSE Composite i.e., NYSE Composite and Lipella Pharmaceuticals go up and down completely randomly.
Pair Corralation between NYSE Composite and Lipella Pharmaceuticals
Assuming the 90 days trading horizon NYSE Composite is expected to generate 20.32 times less return on investment than Lipella Pharmaceuticals. But when comparing it to its historical volatility, NYSE Composite is 16.44 times less risky than Lipella Pharmaceuticals. It trades about 0.02 of its potential returns per unit of risk. Lipella Pharmaceuticals Common is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 312.00 in Lipella Pharmaceuticals Common on December 30, 2024 and sell it today you would lose (53.00) from holding Lipella Pharmaceuticals Common or give up 16.99% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
NYSE Composite vs. Lipella Pharmaceuticals Common
Performance |
Timeline |
NYSE Composite and Lipella Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Lipella Pharmaceuticals Common
Pair trading matchups for Lipella Pharmaceuticals
Pair Trading with NYSE Composite and Lipella Pharmaceuticals
The main advantage of trading using opposite NYSE Composite and Lipella Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Lipella Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lipella Pharmaceuticals will offset losses from the drop in Lipella Pharmaceuticals' long position.NYSE Composite vs. Corby Spirit and | NYSE Composite vs. Church Dwight | NYSE Composite vs. Nascent Wine | NYSE Composite vs. Crocs Inc |
Lipella Pharmaceuticals vs. Senti Biosciences | Lipella Pharmaceuticals vs. Fennec Pharmaceuticals | Lipella Pharmaceuticals vs. Monopar Therapeutics | Lipella Pharmaceuticals vs. Akeso, Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |